M. S. Lin

447 total citations
20 papers, 342 citations indexed

About

M. S. Lin is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Surgery. According to data from OpenAlex, M. S. Lin has authored 20 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 5 papers in Pharmacology and 3 papers in Surgery. Recurrent topics in M. S. Lin's work include Blood Pressure and Hypertension Studies (5 papers), Neuropeptides and Animal Physiology (3 papers) and Heart Rate Variability and Autonomic Control (2 papers). M. S. Lin is often cited by papers focused on Blood Pressure and Hypertension Studies (5 papers), Neuropeptides and Animal Physiology (3 papers) and Heart Rate Variability and Autonomic Control (2 papers). M. S. Lin collaborates with scholars based in United States, China and Taiwan. M. S. Lin's co-authors include Alexander M. M. Shepherd, J. L. McNay, Thomas M. Ludden, Yang-Shia Dai, Yung‐Hsiang Chen, Raoh‐Fang Pwu, T. Kent Keeton, Чиа-Чи Ченг, XinXin Ge and Hui Deng and has published in prestigious journals such as Annals of Internal Medicine, Journal of Controlled Release and Hypertension.

In The Last Decade

M. S. Lin

20 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. S. Lin United States 9 85 72 62 49 42 20 342
Christopher J. Needs Australia 9 100 1.2× 55 0.8× 56 0.9× 66 1.3× 26 0.6× 13 484
Anil Pareek India 12 115 1.4× 48 0.7× 45 0.7× 30 0.6× 49 1.2× 29 443
S K Garg India 12 40 0.5× 41 0.6× 34 0.5× 50 1.0× 24 0.6× 30 485
G Lévy United States 9 162 1.9× 80 1.1× 55 0.9× 44 0.9× 46 1.1× 18 511
Nitin Chandurkar India 12 109 1.3× 68 0.9× 29 0.5× 20 0.4× 52 1.2× 24 387
Heike Weißer Germany 15 70 0.8× 78 1.1× 84 1.4× 27 0.6× 74 1.8× 36 578
Kazushi Sakurai Japan 10 78 0.9× 63 0.9× 130 2.1× 36 0.7× 65 1.5× 18 520
B. H. Ch. Stricker Netherlands 10 100 1.2× 194 2.7× 81 1.3× 137 2.8× 42 1.0× 16 551
Hyewon Chung South Korea 16 50 0.6× 46 0.6× 128 2.1× 52 1.1× 30 0.7× 45 592
Frölich Jc Germany 11 224 2.6× 78 1.1× 104 1.7× 73 1.5× 121 2.9× 33 607

Countries citing papers authored by M. S. Lin

Since Specialization
Citations

This map shows the geographic impact of M. S. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. S. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. S. Lin more than expected).

Fields of papers citing papers by M. S. Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. S. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. S. Lin. The network helps show where M. S. Lin may publish in the future.

Co-authorship network of co-authors of M. S. Lin

This figure shows the co-authorship network connecting the top 25 collaborators of M. S. Lin. A scholar is included among the top collaborators of M. S. Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. S. Lin. M. S. Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dai, Yun, Guodao Zhang, Yisu Ge, et al.. (2025). Low-computational EMG gesture recognition for prosthetic control via handcrafted features and lightweight MLP. Results in Engineering. 27. 106602–106602. 1 indexed citations
2.
Lin, M. S., et al.. (2025). A bibliometric analysis of the advance of artificial intelligence in medicine. Frontiers in Medicine. 12. 1504428–1504428. 7 indexed citations
3.
Lin, M. S., et al.. (2024). Association between increased systemic immune-inflammation index and postoperative delirium in older intertrochanteric fracture patients. Journal of Orthopaedic Surgery and Research. 19(1). 8 indexed citations
4.
Hu, Jiajun, XinXin Ge, M. S. Lin, et al.. (2024). Hyperglycemia-responsive nitric oxide-releasing biohybrid cryogels with cascade enzyme catalysis for enhanced healing of infected diabetic wounds. Journal of Controlled Release. 378. 912–931. 11 indexed citations
5.
Huang, Ying, et al.. (2021). Effect of Jianpibufei plaster on chronic obstructive pulmonary disease in mice. Food Science and Technology. 41(4). 1050–1055. 3 indexed citations
6.
Wu, Zhi‐Juan, et al.. (2021). [TRPV4 channel mediates the increase of pulmonary microvascular endothelial permeability in rats with chronic hypoxic pulmonary hypertension].. PubMed. 73(6). 867–877. 1 indexed citations
7.
Ченг, Чиа-Чи, et al.. (2012). A comprehensive 4-year survey of adverse drug reactions using a network-based hospital system. Journal of Clinical Pharmacy and Therapeutics. 37(6). 647–651. 15 indexed citations
8.
Lin, M. S., et al.. (2005). Risk estimates for drugs suspected of being associated with Stevens‐Johnson syndrome and toxic epidermal necrolysis: a case‐control study. Internal Medicine Journal. 35(3). 188–190. 58 indexed citations
9.
Lin, M. S., et al.. (1996). Comparisons of long-term effects of lisinopril vs nifedipine vs conventional therapy in the treatment of mild-to-moderate hypertension in patients with chronic obstructive pulmonary disease.. PubMed. 57(6). 392–400. 5 indexed citations
10.
Shepherd, Alexander M. M., et al.. (1983). Baroreflex sensitivity modulates vasodepressor response to nitroprusside.. Hypertension. 5(1). 79–85. 14 indexed citations
11.
Lin, M. S., et al.. (1983). Increased plasma norepinephrine accompanies persistent tachycardia after hydralazine.. Hypertension. 5(2). 257–263. 13 indexed citations
12.
Ludden, Thomas M., M. S. Lin, Alexander M. M. Shepherd, & J. L. McNay. (1982). Determination of acetylator phenotype in hypertensive patients with renal impairment. Clinical Pharmacology & Therapeutics. 31(2). 245–246. 5 indexed citations
13.
Lin, M. S., J. L. McNay, & Alexander M. M. Shepherd. (1982). Discordant effects of nitroprusside and hydralazine on heart rate and plasma norepinephrine concentration. Clinical Pharmacology & Therapeutics. 31(2). 244–245. 1 indexed citations
14.
Ludden, Thomas M., J. L. McNay, Alexander M. M. Shepherd, & M. S. Lin. (1982). Clinical Pharmacokinetics of Hydralazine. Clinical Pharmacokinetics. 7(3). 185–205. 120 indexed citations
15.
Ludden, Thomas M., Alexander M. M. Shepherd, J. L. McNay, & M. S. Lin. (1981). A-1. Dose-independent hydralazine pharmacokinetics after intravenous administration to hypertensive patients. Clinical Pharmacology & Therapeutics. 29(2). 262–263. 2 indexed citations
16.
Shepherd, Alexander M. M., M. S. Lin, & T. Kent Keeton. (1981). Hypoglycemia-Induced Hypertension in a Diabetic Patient on Metoprolol. Annals of Internal Medicine. 94(3). 357–358. 7 indexed citations
17.
Ludden, Thomas M., J. L. McNay, Alexander M. M. Shepherd, & M. S. Lin. (1981). Variability of plasma hydralazine concentrations in male hypertensive patients. Arthritis & Rheumatism. 24(8). 987–992. 15 indexed citations
18.
Shepherd, Alexander M. M., et al.. (1981). Plasma concentration and acetylator phenotype determine response to oral hydralazine.. Hypertension. 3(5). 580–585. 46 indexed citations
19.
Shepherd, Alexander M. M., M. S. Lin, T. Kent Keeton, & J. L. McNay. (1981). Plasma Noradrenaline as a Measure of Baroreflex Sensitivity in Hypertensive Man. Clinical Science. 61(s7). 165s–168s. 9 indexed citations
20.
Shepherd, Alexander M. M., M. S. Lin, Thomas M. Ludden, & J. L. McNay. (1979). Relationships between plasma hydralazine (H) concentrations and hypotensive response in patients. Clinical research. 27(5). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026